Australia
# |
Name |
Operating Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
55.74%
|
June 30, 2024 | USD 7.27 | 0.71% |
|
Australia |
|
2 |
12.55%
|
June 30, 2024 | USD 169.95 | -0.56% |
|
Australia |
|
3 |
10.45%
|
Dec. 31, 2023 | USD 18.33 | -0.84% |
|
Australia |
|
4 |
9.31%
|
June 30, 2024 | USD 0.74 | 1.48% |
|
Australia |
|
5 |
8.25%
|
June 30, 2024 | USD 2.33 | 0.08% |
|
Australia |
|
6 |
1.13%
|
June 30, 2024 | USD 1.23 | -0.40% |
|
Australia |
|
7 |
-2.10%
|
June 30, 2024 | USD 0.74 | 0.62% |
|
Australia |
|
8 |
-118.32%
|
June 30, 2024 | USD 2.04 | -5.56% |
|
Australia |
|
9 |
-389.35%
|
June 30, 2024 | USD 2.46 | 10.79% |
|
Australia |
|
10 |
-487.69%
|
June 30, 2024 | USD 4.80 | 5.03% |
|
Australia |
|
11 |
-1,425.74%
|
June 30, 2024 | USD 1.90 | -4.74% |
|
Australia |
|
12 |
-1,718.11%
|
Dec. 31, 2023 | USD 6.16 | 2.82% |
|
Australia |
|
13 |
-2,293.26%
|
June 30, 2024 | USD 2.09 | 0.97% |
|
Australia |
|
14 |
-153,885.37%
|
June 30, 2024 | NA |
|
Australia |
||
15 |
-250,341.67%
|
June 30, 2024 | USD 1.67 | 2.45% |
|
Australia |
The Clinical Trials company in Australia with the highest Operating Income Margin is Clinuvel Pharmaceuticals Limited (ASX: CUV.AX) at 55.74%.
The Clinical Trials company in Australia with the lowest Operating Income Margin is Incannex Healthcare Limited (NasdaqGM: IXHL) at -250,341.67%.
The top 10 Clinical Trials companies in Australia by Operating Income Margin are Clinuvel Pharmaceuticals Limited, CSL Limited, Telix Pharmaceuticals Limited, Cogstate Limited, Australian Clinical Labs Limited, PolyNovo Limited, Monash IVF Group Limited, Immuron Limited, Clarity Pharmaceuticals Ltd and Alterity Therapeutics Limited.
The bottom 10 Clinical Trials companies in Australia by Operating Income Margin are Incannex Healthcare Limited, Opthea Limited, Immutep Limited, Anteris Technologies Ltd, Mesoblast Limited, Alterity Therapeutics Limited, Clarity Pharmaceuticals Ltd, Immuron Limited, Monash IVF Group Limited and PolyNovo Limited.